Prosiectau (45)
Cardiff University Schools involved in this Project
Neurobiological predictors of Huntington's disease (PREDICT) (01.09.2005 - 31.08.2010)
- Rosser, Anne
Neuronal thalamic gap junctions: identity, location and role in slow EEG rhythms of patho(physiological) states (01.01.2006 - 01.01.2009)
- Crunelli, Vincenzo
Nanotether Biochemistry (22.10.2007 - 31.12.2010)
- Dale, Trevor
Nuclesome positioning factors and DNA double-strand breaks (09.06.2008 - 08.06.2011)
- Kent, Nick
Novel anti-malarial compounds and assay targeting chloroquine resistance (01.10.2009 - 31.08.2010)
- Murray, Jim
NANOFATE - Nanoparticle fate assessment and toxicity in the environment (01.04.2010 - 31.03.2014)
- Kille, Peter
NEXTGEN - Next generation methods to preserve farm animal biodiversity by optimizing present and future breeding options (01.04.2010 - 31.03.2014)
- Bruford, Michael
Next generation nucleosome position and chromatin accessibility mapping (12.04.2010 - 12.04.2011)
- Kent, Nick
NOV (CCN3), a new regulator of skeletal development and disease (21.06.2010 - 20.12.2013)
- Boulter, Catherine
Neurobiological predictors of Huntington's disease (PREDICT) (01.09.2010 - 31.08.2014)
- Rosser, Anne
Nanotether (21.03.2011 - 20.03.2012)
- Dale, Trevor
Nanotether. (21.03.2011 - 20.03.2012)
- Dale, Trevor
New models for preclinical evaluation of drugs efficacy in common solid tumours (01.01.2012 - 31.12.2014)
- Smalley, Matthew
Novel coherent multiphoton microscopy of living cells using nanodiamonds (01.09.2012 - 31.08.2013)
- Borri, Paola
Neuronal correlates and effective CNS drug action (01.02.2013 - 30.04.2015)
- Crunelli, Vincenzo
Novel genetic tools for application in insect pest control (02.05.2013 - 01.11.2014)
- White-Cooper, Helen
Nonlinear plasmonic biosensing and functional imaging (01.07.2013 - 30.06.2015)
- Borri, Paola
Northumberland Wildlife Trust Red Squirrel Project (01.08.2013 - 30.06.2014)
- Bruford, Michael
Novel BC13 inhibitors - target validation and anti-metastatic lead optimisation (01.11.2013 - 31.10.2015)
- Clarkson, Richard
Novel Bel3 inhibitors - target validation and anti-metastatic lead optimisation (06.01.2014 - 31.01.2017)
- Clarkson, Richard
Neurodegeneration triggered by dysfunction of FUS protein - studies of the mechanism using in vivo models (01.04.2014 - 30.11.2017)
- Buchman, Vladimir
Novel strategies for single step molecular diagnostics assays with full dynamic range quantitation (01.04.2014 - 30.11.2017)
- Murray, Jim
Non-Clinical Training Award Cycle 2 (01.09.2014 - 31.08.2018)
- Clarke, Alan
New methods to study altitudinal adaptation on the Tibetan Plateau (15.03.2015 - 30.11.2019)
- Bruford, Michael
New technology for higher resolution non-invasive longitudinal in vivo bioluminescence imaging of foetal neurogenesis (01.01.2016 - 31.12.2016)
- Murray, Jim
Novel functional and genomic studies of corneal epithelial stem cells (01.10.2016 - 31.12.2019)
- Smalley, Matthew
Nucleosome positioning and transcriptional regulation in differentiated drosophila cells (01.02.2017 - 28.08.2020)
- White-Cooper, Helen
Novel in vitro culture platform for water-borne pathogen cryptosporidium (01.09.2017 - 28.02.2021)
- Cable, Joanne
Nightjar diet project II (20.10.2017 - 19.01.2018)
- Thomas, Rob
Neuronal mechanisms of developmental cognitive impairment in the Snord1 16del model for Prader-Willi Syndrome (01.01.2019 - 31.12.2019)
- Wells, Tim
New players in organ size determination and homeostasis (01.01.2019 - 31.03.2023)
- Hamaratoglu Dion, Fisun
New far-red autophagy probe for drug screening in neurodegenerative diseases (01.04.2019 - 30.09.2019)
- Waller-Evans, Helen
New technologies for rapid biodiversity assessments of individuals, populations and ecosystems (15.07.2019 - 01.05.2023)
- Perkins, Sarah
Next generation sputum induction diagnostics to prevent infection in CF (01.11.2019 - 31.08.2022)
- Mahenthiralingam, Eshwar
Novel strategies for cell-based neural reconstruction (01.01.2020 - 31.12.2024)
- Li, Meng
Novel miglustat prodrugs for the treatment of lysosomal storage diseases (03.02.2020 - 02.06.2021)
- Lloyd-Evans, Emyr
Novel technologies for point-of-care genetic testing for SARS-CoV-2 (05.08.2020 - 30.04.2021)
- Jurkowski, Tomasz
Non-invasive monitoring of pluripotent stem cell differentiation into dopaminergic neurons – an enabling technology for Parkinson’s cell replacement therapy (01.10.2020 - 30.11.2023)
- Lelos, Mariah
Novel natural hemocyanin protein adjuvant for the COVID-19 vaccine market (01.11.2020 - 31.08.2021)
- Young, Mark
Non-invasive chemically-specific imaging of lung inflammation (01.05.2021 - 31.10.2021)
- Borri, Paola
Non-Ubiquitin mediated targeted degradation of pathogenic protein aggregates (01.10.2021 - 31.03.2025)
- Ward, Simon
Non-radiogrphic osteoarthritis: a metabolic, biochemical and RNA expression study in dogs with crinial cruciate ligament disease/rupture. (01.10.2022 - 31.10.2025)
- Mason, Deborah
NETFRESH: Networking the Response of Freshwater ecosystems to environmental change (01.03.2023 - 29.08.2024)
- Windsor, Fredric
Novel Therapeutic Targets in Human Neuronal Models of 1q21.1 duplication syndrome (01.01.2024 - 31.12.2026)
- Syed, Yasir Ahmed
Novel prognostic markers for mast cell tumours in companion animals (29.01.2024 - 31.03.2024)
- Smalley, Matthew